To overcome the high relapse rate of multiple myeloma (MM), a drug delivery coating for functionalization of bone substitution materials (BSM) is reported based on adhesive, catechol-containing and stimuli-responsive polyelectrolyte complexes (PECs). This system is designed to deliver the MM drug bortezomib (BZM) directly to the anatomical site of action. To establish a gradual BZM release, the naturally occurring caffeic acid (CA) is coupled oxidatively to form poly(caffeic acid) (PCA), which is used as a polyanion for complexation. The catechol functionalities within the PCA are particularly suitable to form esters with the boronic acid group of the BZM, which are then cleaved in the body fluid to administer the drug. To achieve a more th...
Development of a successful bioresponsive drug delivery system requires exquisite engineering of mat...
Novel temperature-sensitive micelles, possessing a core-shell structure, were successfully fabricate...
The current need to find new advanced approaches to carry biologically active substances (convention...
The proteasome inhibitor bortezomib (BZM) is one of the most potent anti-cancer drugs in the therapy...
The proteasome inhibitor bortezomib (BZM) is one of the most potent anti-cancer drugs in the therapy...
The proteasome inhibitor bortezomib (BZM) is one of the most potent anti-cancer drugs in the therapy...
The proteasome inhibitor bortezomib (BZM) is one of the most potent anti-cancer drugs in the therapy...
The proteasome inhibitor bortezomib (BZM) is one of the most potent anti-cancer drugs in the therapy...
For the local treatment of bone defects, highly adaptable macromolecular architectures are still req...
We report the use of bis-catecholic polymers as candidates for obtaining effective, tunable gatekeep...
A novel cell-targeting, pH-sensitive polymeric carrier was employed in this study for delivery of th...
An improved interfacial drug delivery system (DDS) based on polyelectrolyte complex (PEC) coatings w...
A novel cell-targeting, pH-sensitive polymeric carrier was employed in this study for delivery of th...
A novel cell-targeting, pH-sensitive polymeric carrier was employed in this study for delivery of th...
ABSTRACT: A novel cell-targeting, pH-sensitive poly-meric carrier was employed in this study for del...
Development of a successful bioresponsive drug delivery system requires exquisite engineering of mat...
Novel temperature-sensitive micelles, possessing a core-shell structure, were successfully fabricate...
The current need to find new advanced approaches to carry biologically active substances (convention...
The proteasome inhibitor bortezomib (BZM) is one of the most potent anti-cancer drugs in the therapy...
The proteasome inhibitor bortezomib (BZM) is one of the most potent anti-cancer drugs in the therapy...
The proteasome inhibitor bortezomib (BZM) is one of the most potent anti-cancer drugs in the therapy...
The proteasome inhibitor bortezomib (BZM) is one of the most potent anti-cancer drugs in the therapy...
The proteasome inhibitor bortezomib (BZM) is one of the most potent anti-cancer drugs in the therapy...
For the local treatment of bone defects, highly adaptable macromolecular architectures are still req...
We report the use of bis-catecholic polymers as candidates for obtaining effective, tunable gatekeep...
A novel cell-targeting, pH-sensitive polymeric carrier was employed in this study for delivery of th...
An improved interfacial drug delivery system (DDS) based on polyelectrolyte complex (PEC) coatings w...
A novel cell-targeting, pH-sensitive polymeric carrier was employed in this study for delivery of th...
A novel cell-targeting, pH-sensitive polymeric carrier was employed in this study for delivery of th...
ABSTRACT: A novel cell-targeting, pH-sensitive poly-meric carrier was employed in this study for del...
Development of a successful bioresponsive drug delivery system requires exquisite engineering of mat...
Novel temperature-sensitive micelles, possessing a core-shell structure, were successfully fabricate...
The current need to find new advanced approaches to carry biologically active substances (convention...